Rebooting Business Speaker Details

James Lacey, Jr., MPH, PhD

Professor and Director, Division of Health Analytics, Department of Computational and Quantitative Medicine @
City of Hope Comprehensive Cancer Center

Session:

How Science is Taking On COVID-19

June 17, 2020 (On-demand)

Dr. Lacey is the director of the Division of Health Analytics within the Department of Computational and Quantitative Medicine at Beckman Research Institute of City of Hope and serves as Principal Investigator for the California Teachers Study project.

Lacey’s work has been key in demonstrating that women using menopausal progestins and estrogens are more likely to develop uterine and ovarian cancer. He is continuing to investigate how hormones affect the risk of developing uterine cancer, ovarian cancer, breast cancer and other diseases among women.
 
Dr. Lacey received his Ph.D. from the Horace H. Rackham School of Graduate Studies of the University of Michigan. After completing a postdoctoral fellowship at the National Cancer Institute (NCI), Dr. Lacey was an Investigator in the NCI’s Division of Cancer Epidemiology and Genetics from 2001 to 2009. He joined the faculty at City of Hope in 2009; his primary research interest is the epidemiology of breast, uterine, and ovarian cancers.

James on Social

LinkedIn: @jameslaceyjr

veventaas-powered-logo-grad.png